Unclaimed brand
Explore Cureline’s biospecimen bank offering HBS biobanking and lab services for accelerated drug R&D and Dx developement for global research since 2003.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#EE312D
Pomegranate
238, 49, 45
1, 85, 55
0, 79, 81, 7
#F7B4AA
Rose Bud
247, 180, 170
8, 83, 82
0, 27, 31, 3
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
Cureline, Inc. is a global biobank and human biospecimen CRO founded in California’s San Francisco Bay Area in 2003. The company supports drug research and diagnostic development through biobanking, laboratory analysis, and translational and precision medicine services. Its global clinical network spans more than 150 validated clinical sites, with partners across the Americas, Europe, Asia, and Africa.
Cureline offers custom biospecimen procurement and standard or tailored protocols, including fresh and frozen human tissues, blood and biofluids, primary blood and bone marrow cells, and formalin-fixed, paraffin-embedded tumor tissues. Its collections include oncology specimen sets, immuno-oncology samples for functional assays, normal controls, and validated biospecimen sets for biomarker development. Services include translational histopathology, molecular studies, fresh tumor tissue analysis, digital pathology, tissue microarrays, target validation, and glycoproteomics and biomarker discovery. The Cureline Group combines biobanking and analytical capabilities through its specialized pathology, molecular, and biomarker laboratories. It reports serving 700 clients and participating in the NIH TCGA and CPTAC research consortiums.
Company type
Privately Held
Year founded
2003
Company size
11-50 employees
The Cureline name, logos and brand assets are trademarks of Cureline and its affiliates. Brandfetch isn't affiliated with or endorsed by Cureline. Their use is subject to Cureline's brand guidelines.
